Thursday, 28 March 2024


Korean firm launches PlaClin-M, a revolutionary disinfection device

24 March 2023 | News

PlaClin-M is a compact and easy-to-use device that can be quickly utilised in any space

image credit- prnewswire

image credit- prnewswire

CodeSteri, a leading provider of disinfection solutions in South Korea, has announced the launch of PlaClin-M, a revolutionary device designed to help ensure a clean and safe environment in offices, commercial establishments, and public spaces. CodeSteri started from the Korean government project to combat new infectious diseases by the incumbent professor and MD of Hanyang University Emergency Medicine, Seoul.

CodeSteri, with a $4.2 million grant from the Korean government, developed 'PlaClin' after 5 years of R&D efforts with top experts in related fields commencing from 2015 when Mers hit Korea hard. PlaClin was awarded as an "Innovative Product" by the Ministry of Science and ICT and patented in USA and Korea.

The PlaClin solution is widely used by public sector agencies in Korea. The ambulances run by the government gained a big increase in operational effectiveness and cost savings by reducing the wait (reuse) time of COVID-19 carrying ambulances after disinfection from 1~2 hour to 10 to 20 minutes by switching to the PlaClin solution.

New infectious diseases with high mortality and contagiousness occur periodically at intervals of 3 to 4 years worldwide and are expected to repeat in the future as evidenced by Swine Flu 2009, Ebola 2013, Mers 2015, and COVID 2019.

PlaClin solution is eco-friendly disinfection harmless to both humans and devices, with FDA and CE certifications. It offers wide protection from cold, flu, food poisoning, and tuberculosis to high levels of sterilization in intensive care units, operating rooms, etc. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account